Tapan Shah Headshot
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
April 03, 2024 08:05 ET | Tevogen Bio Inc
Mr. Shah, a Wall Street veteran with over 25 years of experience, brings broad leadership capabilities to Tevogen Bio.
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
February 01, 2024 08:15 ET | Semper Paratus Acquisition Corporation
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company,...